Kyowa Kirin Co., Ltd. (KYKOF)
USD 16.05
(0.0%)
USD 16.05
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 86.43 Billion JPY | 39.59% |
| 2022 | 68.66 Billion JPY | 12.25% |
| 2021 | 61.16 Billion JPY | 16.37% |
| 2020 | 52.56 Billion JPY | 14.75% |
| 2019 | 45.8 Billion JPY | -38.95% |
| 2018 | 75.03 Billion JPY | 29.97% |
| 2017 | 57.73 Billion JPY | 82.47% |
| 2016 | 31.63 Billion JPY | -27.71% |
| 2015 | 43.76 Billion JPY | 20.99% |
| 2014 | 36.17 Billion JPY | -30.13% |
| 2013 | 51.77 Billion JPY | -2.14% |
| 2012 | 52.9 Billion JPY | -37.81% |
| 2011 | 85.07 Billion JPY | 87.35% |
| 2010 | 45.41 Billion JPY | 0.0% |
| 2009 | - JPY | -100.0% |
| 2008 | 39.39 Billion JPY | 30.6% |
| 2007 | 30.16 Billion JPY | 18.12% |
| 2006 | 25.53 Billion JPY | -23.79% |
| 2005 | 33.5 Billion JPY | 24.86% |
| 2004 | 26.83 Billion JPY | 42.93% |
| 2003 | 18.77 Billion JPY | -7.77% |
| 2002 | 20.35 Billion JPY | 14.93% |
| 2001 | 17.71 Billion JPY | -18.21% |
| 2000 | 21.65 Billion JPY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 16.49 Billion JPY | -55.73% |
| 2024 Q2 | 24.53 Billion JPY | 48.74% |
| 2023 Q4 | 37.25 Billion JPY | -2.94% |
| 2023 FY | 95.84 Billion JPY | 39.59% |
| 2023 Q1 | 15.61 Billion JPY | 112.92% |
| 2023 Q3 | 38.38 Billion JPY | 266.1% |
| 2023 Q2 | 10.48 Billion JPY | -32.84% |
| 2022 FY | 68.66 Billion JPY | 12.25% |
| 2022 Q3 | 17.56 Billion JPY | -18.83% |
| 2022 Q4 | 7.33 Billion JPY | -58.25% |
| 2022 Q1 | 19.35 Billion JPY | 3.92% |
| 2022 Q2 | 21.63 Billion JPY | 11.76% |
| 2021 Q3 | 11.55 Billion JPY | -22.86% |
| 2021 FY | 61.16 Billion JPY | 16.37% |
| 2021 Q1 | 16.25 Billion JPY | 98.86% |
| 2021 Q2 | 14.97 Billion JPY | -7.89% |
| 2021 Q4 | 18.62 Billion JPY | 61.28% |
| 2020 Q2 | 15.39 Billion JPY | -1.24% |
| 2020 Q3 | 13.4 Billion JPY | -12.95% |
| 2020 Q4 | 8.17 Billion JPY | -39.01% |
| 2020 Q1 | 15.59 Billion JPY | 37.26% |
| 2020 FY | 52.56 Billion JPY | 14.75% |
| 2019 Q3 | 12.08 Billion JPY | 21.96% |
| 2019 Q1 | 12.44 Billion JPY | 11.73% |
| 2019 FY | 45.8 Billion JPY | -38.95% |
| 2019 Q2 | 9.91 Billion JPY | -20.37% |
| 2019 Q4 | 11.35 Billion JPY | -6.03% |
| 2018 Q2 | 15.78 Billion JPY | -48.7% |
| 2018 FY | 75.03 Billion JPY | 29.97% |
| 2018 Q4 | 11.14 Billion JPY | -35.78% |
| 2018 Q3 | 17.34 Billion JPY | 9.92% |
| 2018 Q1 | 30.76 Billion JPY | 31.86% |
| 2017 Q4 | 23.33 Billion JPY | 127.14% |
| 2017 Q3 | 10.27 Billion JPY | 9.01% |
| 2017 FY | 57.73 Billion JPY | 82.47% |
| 2017 Q2 | 9.42 Billion JPY | -35.92% |
| 2017 Q1 | 14.7 Billion JPY | 205.89% |
| 2016 Q3 | 11.49 Billion JPY | 68.78% |
| 2016 Q1 | 8.52 Billion JPY | 195.59% |
| 2016 Q4 | 4.8 Billion JPY | -58.19% |
| 2016 FY | 31.63 Billion JPY | -27.71% |
| 2016 Q2 | 6.81 Billion JPY | -20.07% |
| 2015 Q2 | 13.12 Billion JPY | 40.57% |
| 2015 FY | 43.76 Billion JPY | 20.99% |
| 2015 Q4 | 2.88 Billion JPY | -84.34% |
| 2015 Q3 | 18.41 Billion JPY | 40.25% |
| 2015 Q1 | 9.34 Billion JPY | -5.62% |
| 2014 Q2 | 5.96 Billion JPY | -52.08% |
| 2014 Q4 | 9.89 Billion JPY | 25.81% |
| 2014 FY | 36.17 Billion JPY | -30.13% |
| 2014 Q3 | 7.86 Billion JPY | 31.89% |
| 2014 Q1 | 12.44 Billion JPY | 20.1% |
| 2013 Q3 | 14.23 Billion JPY | 11.97% |
| 2013 Q2 | 12.71 Billion JPY | -12.13% |
| 2013 FY | 51.77 Billion JPY | -2.14% |
| 2013 Q1 | 14.46 Billion JPY | -7.05% |
| 2013 Q4 | 10.36 Billion JPY | -27.18% |
| 2012 Q3 | 11.75 Billion JPY | 55.82% |
| 2012 Q2 | 7.54 Billion JPY | -58.17% |
| 2012 FY | 52.9 Billion JPY | -37.81% |
| 2012 Q1 | 18.03 Billion JPY | 188.91% |
| 2012 Q4 | 15.56 Billion JPY | 32.35% |
| 2011 Q1 | 21.9 Billion JPY | 80.05% |
| 2011 Q3 | 8.55 Billion JPY | 6.64% |
| 2011 Q2 | 8.02 Billion JPY | -63.37% |
| 2011 FY | 85.07 Billion JPY | 87.35% |
| 2011 Q4 | -20.28 Billion JPY | -337.05% |
| 2010 Q1 | 11.52 Billion JPY | 0.0% |
| 2010 Q3 | 11.53 Billion JPY | 13.47% |
| 2010 Q4 | 12.16 Billion JPY | 5.51% |
| 2010 Q2 | 10.16 Billion JPY | -11.82% |
| 2010 FY | 45.41 Billion JPY | 0.0% |
| 2009 Q2 | 11.04 Billion JPY | 0.0% |
| 2009 FY | - JPY | -100.0% |
| 2009 Q3 | 9.73 Billion JPY | -11.8% |
| 2008 Q2 | 17.07 Billion JPY | 0.0% |
| 2008 Q3 | 12.08 Billion JPY | -29.2% |
| 2008 FY | 39.39 Billion JPY | 30.6% |
| 2007 FY | 30.16 Billion JPY | 18.12% |
| 2006 FY | 25.53 Billion JPY | -23.79% |
| 2005 FY | 33.5 Billion JPY | 24.86% |
| 2004 FY | 26.83 Billion JPY | 42.93% |
| 2003 FY | 18.77 Billion JPY | -7.77% |
| 2002 FY | 20.35 Billion JPY | 14.93% |
| 2001 FY | 17.71 Billion JPY | -18.21% |
| 2000 FY | 21.65 Billion JPY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| AstraZeneca PLC | 8.19 Billion USD | -955.035% |
| Bristol-Myers Squibb Company PFD CONV 2 | 17.24 Billion USD | -401.328% |
| CSPC Pharmaceutical Group Limited | 7.01 Billion USD | -1132.025% |
| Clarus Therapeutics Holdings, Inc. | -39.73 Million USD | 217655.119% |
| Novartis AG | 9.76 Billion USD | -784.83% |
| PT Kalbe Farma Tbk. | 3625.13 Billion USD | 97.616% |